Tafinlar/Mekinist (dabrafenib/trametinib)

pCPA File Number: 20826
Negotiation Status:
Concluded with an LOI
Indication(s):
Metastatic Melanoma
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CDA-AMC Project Number:
PC0053-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: